Literature DB >> 32411198

Prevalence of Elevated Alanine Aminotransferase by Diagnostic Criterion, Age, and Gender among Adolescents.

Jing Zhang1, Zheng-Ying Wang1, Jing-Ping Zhang2, Hua Zhou3, Zan Ding3.   

Abstract

BACKGROUND: Serum alanine aminotransferase (ALT) activity was measured not only to detect liver disease, but also to monitor overall health. The purpose of this study was to obtain the prevalence of elevated ALT levels among adolescents.
METHODS: In a school-based cross-sectional study, a representative sample was analyzed from 9 middle and high schools in Shenzhen, China, during 2017 to 2018. Elevated ALT was defined as diagnostic criterion I (>30 U/L for boys and >19 U/L for girls) and diagnostic criterion II (>40 U/L).
RESULTS: From the adolescent population, a total of 7281 students (boys, 4014, and girls, 3267) aged from 10 to 17 years were collected. The prevalence of elevated ALT was 7.11% (6.88% for boys and 7.41% for girls) by criterion I and 2.72% (3.96% for boys and 1.19% for girls) by criterion II. Based on the Shenzhen census and Chinese national census population, the adjusted prevalence of elevated ALT was 7.65% (boys 7.19% and girls 8.21%) and 6.79% (boys 6.07% and girls 7.56%) by criterion I and 2.85% (boys 4.20% and girls 1.16%) and 2.43% (boys 3.49% and girls 1.29%) by criterion II. For age, the overall trends were increasing progressively, regardless of the use of diagnostic criteria for an elevated ALT activity.
CONCLUSIONS: This study supplements the gap that the prevalence of elevated ALT levels differed in gender, age, and criteria among adolescents of Shenzhen. We should take the prevalence as a predictor and continue to play a warning and preventive role in preparation for further intervention.
Copyright © 2020 Jing Zhang et al.

Entities:  

Year:  2020        PMID: 32411198      PMCID: PMC7204184          DOI: 10.1155/2020/4240380

Source DB:  PubMed          Journal:  Gastroenterol Res Pract        ISSN: 1687-6121            Impact factor:   2.260


1. Introduction

Serum alanine aminotransferase (ALT) is a liver enzyme in the cytosol of hepatocytes, and the elevated values are frequently used to evaluate liver dysfunction [1]. As an indicator of health and disease [2], ALT has been proven several times to be a sensitive biochemical marker to screen for the detection of possible diseases, such as cardiovascular complications [3], osteopenia, bone mineral density [4], obstructive sleep apnea-hypopnea syndrome [5], anorexia nervosa [6], and depression [7]. As a part of annual check-ups, ALT levels increased after different kinds of liver injuries and when at risk of hepatitis, liver cirrhosis, liver steatosis, nonalcoholic steatohepatitis, hepatic hypoperfusion, and nonalcoholic fatty liver disease (NAFLD), which were more common in individuals with elevated ALT than with normal ALT [8, 9]. There were different causes of elevated ALT, including obesity-related diseases, hypertension, hyperglycemia, hypertriglyceridemia, diabetes, medication use, and metabolic syndrome [10, 11]. It is necessary to evaluate the prevalence of elevated ALT, which could be used as one of the surrogate markers of overall health in a general population. Numerous national studies found that the prevalence of elevated ALT levels among adults and adolescents varied from different countries, ethnic groups, gender, age, and different diagnostic criteria [12-16]. Among adolescents, the prevalence of elevated ALT was shown in the U.S. [17-20], Korea [12, 21], Mexico [22, 23], China [10], Netherlands [24], and Iran [25]. The considerably different prevalence had pointed out the importance of standardizing and documenting the variations of ALT levels. Moreover, adolescents have been one of the group of greatest concern to society, because due to rapid growth at youth, the abnormalALT elevation may have further influence among adolescents than adults in the future for overall health [1, 26]. However, the prevalence of elevated ALT among adolescents had not been adequately evaluated in mainland China, especially in the new metropolis of Shenzhen. As one of the super bigger and newest first-tier cities worldwide, the total area of Shenzhen was 1997.3 km2 and the population was around 11.37 million with about 70% being migrants. Therefore, we really need to implement a clinical survey and to analyze the prevalence of elevated ALT among the adolescents of Shenzhen, China, in a cross-sectional study. The objectives of the present study were to examine the crude and standardized prevalence of elevated ALT for the total adolescent group as well as the subgroups by age and gender and to summarize the prevalence of elevated ALT among adolescents all over the world.

2. Materials and Methods

2.1. Study Population

The current study was conducted in Shenzhen, located in the Pearl River Delta region in southern China. As the first special economic zone of China and one of the largest manufacturing bases in the world, Shenzhen has a total gross domestic product (GDP) of 0.27 trillion USD and 24,640 USD per capita in 2015. We implemented a school-based descriptive survey and recruited all the freshmen from 9 junior and senior high schools (HangCheng School, Baoan Vocational Technical School, Oriental English School, HeZhou School, HuangMaBu School, JinBi Experimental School, KangQiao School, LongShan School, and ZhongAo Experimental School) [27]. The whole clinical data were extracted from the compulsory admission physical examination organized by the Baoan District Government of Shenzhen from February 2017 to June 2018. In this study, adolescents were defined as 10–17 years old. A total of 7382 students initially participated in our study; 28 cases ≥ 18 years old, 16 cases < 10 years old, 41 cases lacked ALT, and 16 cases with missed age were deleted. Finally, 7281 valid samples remained (effective rate 98.6%).

2.2. Data Collection

Demographic information such as age, sex, and grade were obtained from self-administered questionnaires. Anthropometric and laboratory measurements of students were also taken. Height and weight were measured by trained physicians to the nearest 0.5 cm and 0.1 kg, without shoes, socks, and any other heavy clothing. After an overnight fast of 10 h, blood samples were drawn from an antecubital vein in each subject into vacutainer tubes. The tubes were delivered to the laboratory of the hospital in an insulated box with ice by a specially assigned physician and centrifuged within an hour. ALT was measured using the AU5800 serial with the automatic biochemical analyzer (Model AU5821; Tokyo, Japan) by the manufacturing enterprise Beckman Coulter K.K. Written informed consents for each participant and their parents were obtained.

2.3. Definition of Elevated Serum ALT Levels

For adolescents, the common definitions of elevated ALT used were above 30 U/L for boys and above 19 U/L for girls [25, 28]. Besides, ALT values were quantitatively estimated above 40 U/L in previous studies [19, 22]. In the present study, the prevalence of elevated ALT was mainly diagnosed by ALT > 30 U/L for boys and >19 U/L for girls (i.e., criterion I) and ALT > 40 U/L for both sexes (i.e., criterion II).

2.4. Statistical Analysis

The normal distribution of serum ALT was determined by the Shapiro-Wilk test. Significance for intergroup differences was evaluated by the Mann-Whitney U test for the skewed blood index. We combined 10–11-year-old adolescents in the statistical analysis of the ALT abnormality rate, because the sample size of the 10 year olds was too small. The prevalence of elevated ALT with 95% confidence interval (95% CI) was quantitatively estimated, diagnosed by both criteria I and II. Significance for intergroup difference between boys and girls in the prevalence of elevated ALT was assessed by Pearson's chi-square test. A chi-square test for the trend of the crude age-prevalence of elevated ALT was also performed. Age- and/or sex-standardized prevalence rates of elevated ALT were estimated by the direct standardization method, according to the distribution of the population in the 2010 Shenzhen population census (http://www.sztj.gov.cn/xxgk/zfxxgkml/tjsj) as well as the 2010 Chinese population census (http://www.stats.gov.cn/tjsj). Associations with age and gender were examined using multiple logistic regression models, expressed as odds ratios and 95% CIs for risk of elevated ALT. All statistical analyses involved use of SPSS for Windows 13.0 (SPSS Inc., Chicago, IL, USA) and R software version 3.2.0 (http://www.R-project.org, the R Foundation for Statistical Computing, Vienna, Austria), and graphics were carried out by SigmaPlot software version 10.0. Two-tailed tests of significance were reported, and P < 0.05 was considered statistically significant.

3. Results

3.1. Sample Characteristics

Overall, we collected 7281 adolescents aged 10–17 years for analysis, involving 4014 boys and 3267 girls. Table 1 shows the baseline descriptive statistics for the levels of ALT stratified by age and gender. For 10–17 year olds, the mean (standard deviation) value of ALT was separately 15.96 (17.02), 12.18 (11.06), and 14.26 (14.77) U/L for boys, girls, and both genders, respectively. Boys had higher ALT levels than girls (P < 0.001). The concentrations of serum ALT were not normally distributed (P < 0.001). The 5th, 25th, 75th, and 95th percentiles of serum ALT levels were 7, 9, 15, and 30 U/L for overall participants; 7, 10, 16, and 37 U/L for boys; and 6, 9, 13, and 22 U/L for girls, respectively.
Table 1

Baseline descriptive statistics for serum alanine aminotransferase levels (U/L) stratified by gender among the adolescents (aged 10–17 years) of Shenzhen, China, 2017–2018.

Sample N MeanSDMinPercentilesMax
5th10th25th50th75th90th95th99th
Overall (years)
 10.0–10.96011.255.043679101314153339
 11.0–11.996712.236.8537891114172038141
 12.0–12.9151112.679.2917891113182248206
 13.0–13.947114.8521.8437891215202776415
 14.0–14.9110114.2112.7617891114223368193
 15.0–15.9178915.5719.5937891116243575495
 16.0–16.9113615.8015.5437791216253681213
 17.0–17.924615.2911.384789121625336593
 10.0–17.9728114.2614.7717891115213067495
Boys (years)
 10.0–10.93311.215.586679101214153139
 11.0–11.949013.368.52478101215182346141
 12.0–12.989913.398.8027891114192550113
 13.0–13.926913.1710.1247891114192550138
 14.0–14.954616.7416.36178101218274092193
 15.0–15.9101718.2324.313781013182940116495
 16.0–16.962418.5119.453781013193350102213
 17.0–17.913617.1613.6247810121832496593
 10.0–17.9401415.9617.02178101216253779495
Girls (years)
 10.0–10.92711.304.3937710111314162528
 11.0–11.947711.074.243679101216182740
 12.0–12.961211.629.8916791012161943206
 13.0–13.920217.0731.1537891216223096415
 14.0–14.955511.726.892678101316214368
 15.0–15.977212.069.4836781013182346186
 16.0–16.951212.517.443779111420243688
 17.0–17.911012.987.174789121519222969
 10.0–17.9326712.1811.0616791013172246415

ALT: alanine aminotransferase; SD: standard deviation.

3.2. Crude Prevalence of Elevated ALT

As shown in Table S1, a total of 518 and 198 adolescents had abnormal ALT levels separately, based on the diagnostic criteria I (>30 U/L for boys and >19 U/L for girls) and II (>40 U/L). The crude age-prevalence of elevated ALT among adolescents was 7.11% (6.88% for boys and 7.41% for girls) by criterion I and 2.72% (3.96% for boys and 1.19% for girls) by criterion II. Obviously, the prevalence of elevated ALT, influenced by gender and age, was higher by criterion I than by criterion II. In addition, Figure 1 shows the trends of the crude age-prevalence of elevated ALT, which displayed an uptrend by age (both P < 0.001).
Figure 1

Crude age-prevalence of elevated alanine aminotransferase (ALT) based on the diagnostic criteria I (a) and II (b) among the adolescents of Shenzhen, China, 2017–2018.

3.3. Standardized Prevalence of Elevated ALT

According to the Shenzhen census, the overall standardized prevalence of elevated ALT was 7.65% (boys 7.19% and girls 8.21%) by criterion I and 2.85% (boys 4.20% and girls 1.16%) by criterion II; based on the Chinese national census, the standardized prevalence was 6.79% (boys 6.07% and girls 7.56%) by criterion I and 2.43% (boys 3.49% and girls 1.29%) by criterion II (Figure 2). The standardized prevalence of elevated ALT was similar with the results of crude prevalence shown in Table 2.
Figure 2

Standardized prevalence of elevated alanine aminotransferase (ALT) among the adolescents of Shenzhen, China, 2017–2018, diagnosed with both the criteria I and II, based on the 2010 Shenzhen Census Population (a) and the 2010 Chinese National Census Population (b).

Table 2

Crude age-prevalence of elevated alanine aminotransferase (ALT) stratified by gender among the adolescents of Shenzhen, China, 2017–2018, separately based on the diagnostic criteria I and II.

Age (years)Criterion ICriterion II
OverallBoysGirls P valueOverallBoysGirls P value
10–177.11 (6.52-7.7)6.88 (6.09-7.66)7.41 (6.51-8.31)0.3802.72 (2.35-3.09)3.96 (3.36-4.56)1.19 (0.82-1.57) <0.001
10–113.60 (2.46-4.74)2.87 (1.44-4.30)4.37 (2.58-6.15)0.1980.78 (0.24-1.32)1.53 (0.48-2.58)0 (0-0) 0.005
124.37 (3.34-5.40)4.00 (2.72-5.29)4.90 (3.19-6.61)0.4021.79 (1.12-2.45)2.22 (1.26-3.19)1.14 (0.30-1.99)0.119
137.01 (4.70-9.31)2.97 (0.94-5.00)12.38 (7.83-16.92)<0.0012.76 (1.28-4.24)1.49 (0.04-2.93)4.46 (1.61-7.30) 0.052
147.54 (5.98-9.10)8.24 (5.94-10.55)6.85 (4.75-8.95)0.3813.00 (1.99-4.00)4.76 (2.98-6.55)1.26 (0.33-2.19) 0.001
158.66 (7.36-9.97)8.95 (7.19-10.70)8.29 (6.35-10.24)0.6243.41 (2.57-4.25)5.01 (3.67-6.36)1.30 (0.50-2.09) <0.001
1610.39 (8.61-12.16)10.58 (8.16-12.99)10.16 (7.54-12.77)0.8174.05 (2.90-5.20)6.57 (4.63-8.51)0.98 (0.12-1.83) <0.001
1710.57 (6.73-14.41)11.03 (5.76-16.29)10.00 (4.39-15.61)0.7944.07 (1.60-6.53)6.62 (2.44-10.8)0.91 (0-2.68) 0.024

The prevalence of elevated ALT is expressed as % (95% confidence interval). †Diagnostic criterion I: >30 U/L for boys and >19 U/L for girls. ‡Diagnostic criterion II: >40 U/L for boys and girls. ∗P < 0.001 comparing girls with boys by Pearson's chi-square test.

3.4. Univariable and Multivariable Logistic Regression Analyses

Tables 3 and 4 show the outcomes of gender and age difference with elevated ALT by logistic regression analysis. For gender, the abnormal rate of ALT in girls was much higher than that in boys (OR = 1.65, 95% CI: 1.35–2.03) by criterion I, but lower in girls (0.42, 0.29–0.60) by criterion II, after being adjusted for age and body mass index using a multivariable logistic regression. For age, compared to the reference group, the overall trends were increasing progressively, regardless of the use of diagnostic criteria for an elevated ALT activity.
Table 3

Univariate and multivariate logistic regression analyses with elevated alanine aminotransferase (ALT) as the outcome variable, based on the diagnostic criterion I (>30 U/L for boys and >19 U/L for girls).

VariableUnivariate analysisMultivariate analysisa
Wald testOR (95% CI) P Wald testOR (95% CI) P
Girls (vs. boys)0.7701.08 (0.91-1.30)0.38023.5871.65 (1.35-2.03)<0.001
Age (years)62.625<0.00134.547<0.001
 10–111.001.00
 120.9171.22 (0.81-1.84)0.3381.2951.29 (0.83-2.01)0.255
 138.1082.02 (1.24-3.27)0.0047.4312.06 (1.23-3.47)0.006
 1414.8162.18 (1.47-3.25)<0.0015.6011.68 (1.09-2.59)0.018
 1524.7162.54 (1.76-3.66)<0.00112.0892.03 (1.36-3.02)0.001
 1634.1693.10 (2.12-4.53)<0.00119.5352.53 (1.67-3.83)<0.001
 1718.6563.16 (1.88-5.33)<0.00115.9733.17 (1.80-5.58)<0.001
Constant667.963<0.001

Boys or 10–11 years as the reference group; OR (95% CI): odds ratio (95% confidence interval). aAdjusted for gender, age, and body mass index using a multivariable logistic regression analysis.

Table 4

Univariate and multivariate logistic regression analyses with elevated alanine aminotransferase (ALT) as the outcome variable, based on the diagnostic criterion II (>40 U/L for boys and girls).

VariableUnivariate analysisMultivariate analysisa
Wald testOR (95% CI) P valueWald testOR (95% CI) P value
Girls (vs. boys)46.3880.29 (0.21-0.42)<0.00121.1290.42 (0.29-0.60)<0.001
Age (years)28.711<0.00116.5400.011
 10–111.001.00
 124.3152.32 (1.05-5.12)0.0383.8722.32 (1.00-5.38)0.049
 138.0543.62 (1.49-8.78)0.0059.4924.31 (1.70-10.92)0.002
 1411.9403.94 (1.81-8.56)0.0017.9453.24 (1.43-7.35)0.005
 1515.8084.50 (2.14-9.43)<0.0018.5933.21 (1.47-6.99)0.003
 1619.0305.38 (2.53-11.44)<0.00111.0863.90 (1.75-8.69)0.001
 1712.3465.40 (2.11-13.82)<0.00110.6455.34 (1.95-14.60)0.001
Constant268.333<0.001

Boys or 10–11 years as the reference group; OR (95% CI): odds ratio (95% confidence interval). aAdjusted for gender, age, and body mass index using a multivariable logistic regression analysis.

3.5. The Prevalence of Elevated ALT among Adolescents Worldwide

In Table 5, we summarized the prevalence of elevated ALT among adolescents worldwide. The prevalence of elevated ALT among adolescents differed by the sex ratio and age of objects, area, ethnicity, study period, and diagnostic criterion [19, 22, 23, 29–31].
Table 5

Summaries of the prevalence of elevated ALT among adolescents for serum alanine aminotransferase (ALT) worldwide.

No.StudyCountryTarget populationAge (years)Sample sizeDefinition (U/L)Prevalence of elevated ALT
1Kim et al. [21](2018)KoreaAdolescents10-188455>305.3% in total8.0% in boys2.1% in girls
>402.8% in total
>33 for boys>25 for girls5.4% in total

2Ruhl and Everhart [18](2013)U.S.Adolescents12-199361>31 for boys>24 for girls10.8% am and 11.3% pm in boys7.3% am and 7.8% pm in girls

3Kong et al. [35](2008)ChinaAdolescents12-182102>403.2% in total
>305.9% in total

4Fraser et al. [19](2007)U.S.Adolescents12-195586>308.0% in total5.6% in boys1.6% in girls7.4% in white11.5% in Mexican Americans6.0% in black10.6% in multiracial and other Hispanics
>403.6% in total5.6% in boys1.6% in girls3.1% in white6.1% in Mexican Americans2.3% in black

5Strauss et al. [20](2000)U.S.Overweight and obese adolescents12-182450>306% in overweight20% in obesity

6Park et al. [12](2005)KoreaAdolescents10-191594>403.6% in boys2.8% in girls

7Wu et al. [10](2012)ChinaStudents12-246997≥403.1% in total4.8% in boys1.5% in girls

8Park et al. [33](2012)KoreaAdolescents12-181591>33 for boys>25 for girls5.9% in total15.7% in overweight34.9% in obesity

9Fermin et al. [17](2017)U.S.Adolescents12-195411>309.14% in total8.74% in non-Hispanic white5.49% in non-Hispanic black13.33% in Hispanic
>22 for girls>25 for boys16.25% in total

10DeBoer et al. [42](2013)U.S.Adolescents12-194124>309.0% in total13.7% in Hispanics8.6% in non-Hispanic white5.4% in non-Hispanic blacks

11Ramirez-Lopez et al. [22](2018)MexicoAdolescents14-19674>403.0% in total14.1% in obesity1.81% in nonobesity

12Purcell et al. [23](2013)MexicoYouth8-191262>409.8% in boys3.8% in girls28.9% in obesity14.2% in overweight40.0% in metabolic syndrome boys14.5% in metabolic syndrome girls

13Elizondo-Montemayor et al. [32](2014)MexicoObese and overweight children6-12236>4017.7% in total

14Samani et al. [25](2011)IranChildren and adolescents6-181172>30 for boys>19 for girls4.9% in boys7.45% in girls

15Wang et al. [43](2018)KoreaHealthy adolescents10-181785>24.1 for boys>17.7 for girls14.9% in boys12.3% in girls

16van Vliet et al. [24](2009)NetherlandsOverweight and obese children3-18443>3020.3% in total25.8% in boys13.8% in girls

17Park et al. [28](2013)KoreaAdolescents10-182242>30 for boys>19 for girls7.9% in boys10.2% in girls

4. Discussion

Shenzhen is a vibrant city with a large number of immigrants, and the majority of the population here lives in a fast-paced and rapid-developing social environment [32]. This study examined the crude and standardized prevalence of elevated ALT among adolescents of Shenzhen for the total group and subgroups, showing that the prevalence of elevated ALT increased with age and differed by gender at puberty. The levels of ALT may be influenced by different variations including region, ethnic groups, overweight, obesity, liver diseases, and other factors, and we therefore summarized the prevalence of elevated ALT among adolescents on a global scale.

4.1. Diagnostic Criteria for Elevated ALT Levels

Nowadays, almost all countries use gender-specific criteria to determine the elevated ALT levels rather than the single standard usually used [18, 21, 33]. Our results obtained the prevalence of elevated ALT for boys and girls in diagnostic criteria I (>30 U/L for boys and >19 U/L for girls) and II (>40 U/L). Aside from the two main criteria above used in our study, there were other criteria (e.g., ALT > 33 U/L for boys and >25 U/L for girls [33], >30 U/L for boys and >21 U/L for girls [34], and >30 U/L for both sexes [24]) with which to diagnose an elevated ALT activity.

4.2. The Prevalence of Elevated ALT

Based on various criteria, the abnormal rates of elevated ALT obviously differed. Among the adolescents of Shenzhen, the prevalence of elevated ALT was 7.11% by criterion I and 2.72% by criterion II; in Korea, 7.9% for boys and 10.2% for girls by criterion I [28] and 3.6% for boys and 2.8% for girls by criterion II [12]; and in Hong Kong of China, 3.2% by ALT > 40 U/L and 5.9% by ALT > 30 U/L [35]. From Table 5, the prevalence of elevated ALT among adolescents ranged from 1.5% in mainland China for girls [10] to 34.9% in Korea for obese populations [33]. The prevalence of elevated ALT is diverse in different national groups, such as 4.9% for boys and 7.5% for girls in Iran by criterion I [25], 3.0% in Mexico (>40 U/L) [22], 8.0% in the U.S. (>30 U/L) [19], 3.1% in China (≥40 U/L) [10], and 5.3% (>30 U/L) and 2.8% (>40 U/L) in Korea [34].

4.3. Prevalence of Elevated ALT Differed by Gender

Gender differences turned up in our study; for example, the proportion of the abnormal rate was higher for girls than boys by criterion I (7.41% vs. 6.88%, respectively) but lower by criterion II (1.19% vs. 3.96%, respectively). Evaluating the abnormal ALT levels by gender shows more individuality than gender-neutral assessment. Most studies reported different prevalence rates of elevated ALT by gender (e.g., 8.0% for boys and 2.1% for girls in Korea [21], 5.6% for boys and 1.6% for girls in the U.S. [19], 4.8% for boys and 1.5% for girls in mainland China [10], and 9.8% for boys and 3.8% for girls in Mexico [23]). The levels of serum ALT were higher in boys than in girls, which may relate to the differences in muscle mass and endogenous hormone levels (self-undetermined physical and emotional factors) between genders [36-39]. In this regard, it is well acknowledged that serum concentrations of estradiol are low in preadolescent girls and increase at menarche [40, 41]. The age-related hormonal changes could partly account for the ALT levels that we observed between genders.

4.4. Prevalence of Elevated ALT Differed by Age

With the metabolic liver diseases gradually becoming younger currently, the abnormal rates of elevated ALT clearly reflected an uptrend with growing age. Focused on the Shenzhen adolescents of 10–17 years, the prevalence of elevated ALT was a rising tendency with increasing age, regardless of the use of criterion I or II. For adults, the Rancho Bernardo Study cohort showed that the levels of ALT were highest in a young group (30–62 years) and subsequently decreased with increasing age among 63–93 years [16]; another longitudinal study also reported similar findings that the mean levels of ALT decreased with age in elders, with a mean age of 65.7 years [29]. From the above two studies, we could know the downtrend with age of ALT levels in the elderly age range. Containing 335 subjects (≥18 years), a Jerusalem study on age-ALT association reported the peaking age (40–55 years) from an inverted U curve [15]. Thus, uptrend with age in the adolescent period should probably be taken into account.

4.5. Other Influencing Factors for Abnormal ALT Levels

Except for the above four factors (i.e., diagnostic criterion, age, gender, and region), ethnicity may be a potential influencing factor to affect the prevalence of elevated ALT levels. It was significant to note that ethnics affect the abnormal rate in several studies (e.g., 13.7% in Hispanics, 8.6% in non-Hispanic whites, and 5.4% in non-Hispanic blacks [42]; 7.4% among whites, 6.0% among blacks, 11.5% in Mexican Americans, and 10.6% in multiracial and other Hispanic adolescents [19]). It has been reported that ALT levels and the prevalence of elevated ALT were more common in overweight or obese adolescents (e.g., 6% of the overweight and 20% of the obese in the U.S. [20], 15.7% of the overweight and 34.9% of the obese in Korea [16], and 14.2% of the overweight and 28.9% of the obese in Mexico [33]). The levels of ALT were closely connected with the damage of hepatocyte and hepatic enzymes. Elevated ALT played a predictive role in the diagnosis of liver diseases (e.g., NAFLD and metabolic liver diseases), which were prevalent but concealed in adolescents [43]. Furthermore, bad living habits (e.g., staying up late, lack of exercise, and increasingly sedentary lifestyle), unhealthy eating behaviors (e.g., drinking beverage, snacking, and take-away meal habits), and living settings were potentially important factors. From the above, healthy lifestyle and dietary intervention are crucial to weight loss and to keep adolescents healthy.

4.6. Limitations

Several potential limitations of our research should be acknowledged. First, participants were only from a single city of China, and it therefore might be difficult to generalize these findings for adolescents of other regions. Second, alcohol consumption and hepatitis B virus (HBV) and hepatitis C virus (HCV) infections were less common and out of our considerations [44, 45]. Third, the lack of comprehensive evaluation of individualized specific characteristics was not enough to conduct a further interventional study on the basis of this study.

5. Conclusions

The prevalence of elevated ALT levels differed in gender, age, and criteria among adolescents of Shenzhen. As the high growth period, adolescents have become a focus of public and national health; strengthening healthy education and lifestyle management may be benefits to their healthy growth. With timely attention to age and gender differences of adolescents during their earlier identification of elevated ALT, more adolescents may avoid the diagnosis of elevated ALT-related diseases, especially for boys and high school students. Consequently, we should take the prevalence as a predictor and continue to play a warning and preventive role in preparation for further intervention.
  45 in total

Review 1.  Hormone supplementation for pubertal induction in girls.

Authors:  Debbie Matthews; Louise Bath; Wolfgang Högler; Avril Mason; Arlene Smyth; Mars Skae
Journal:  Arch Dis Child       Date:  2017-04-26       Impact factor: 3.791

2.  The association of alanine transaminase with aging, frailty, and mortality.

Authors:  David G Le Couteur; Fiona M Blyth; Helen M Creasey; David J Handelsman; Vasi Naganathan; Philip N Sambrook; Markus J Seibel; Louise M Waite; Robert G Cumming
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-05-24       Impact factor: 6.053

3.  Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.

Authors:  Chien-Hua Chen; Min-Ho Huang; Jee-Chun Yang; Chiu-Kue Nien; Chi-Chieh Yang; Yung-Hsiang Yeh; Sen-Kou Yueh
Journal:  J Gastroenterol Hepatol       Date:  2007-09       Impact factor: 4.029

4.  Alanine aminotransferase decreases with age: the Rancho Bernardo Study.

Authors:  Mamie H Dong; Ricki Bettencourt; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

5.  Association of ALT and the metabolic syndrome among Mexican children.

Authors:  Leticia Elizondo-Montemayor; Patricia A Ugalde-Casas; Lorena Lam-Franco; Humberto Bustamante-Careaga; Mónica Serrano-González; Norma G Gutiérrez; Ubaldo Martínez
Journal:  Obes Res Clin Pract       Date:  2014 Jan-Feb       Impact factor: 2.288

6.  The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin.

Authors:  Mariska van Vliet; Inès A von Rosenstiel; Roger K Schindhelm; Desiderius P M Brandjes; Jos H Beijnen; Michaela Diamant
Journal:  Eur J Pediatr       Date:  2008-08-12       Impact factor: 3.183

7.  A seroepidemiological Study of Hepatitis B and C Virus (HBV and HCV) Infections in the Young Population in parts of Busan, Korea.

Authors:  Young Hee Ju; Hai Rim Shin; Jin Kyoung Oh; Dong Il Kim; Duk Hee Lee; Byeong Kweon Kim; Jung Il Kim; Kap Yeol Jung
Journal:  J Prev Med Public Health       Date:  2004-08

8.  Relation of Alanine Aminotransferase Levels to Cardiovascular Events and Statin Efficacy.

Authors:  Paulo H N Harada; Nancy R Cook; David E Cohen; Nina P Paynter; Lynda Rose; Paul M Ridker
Journal:  Am J Cardiol       Date:  2016-04-21       Impact factor: 2.778

9.  Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population.

Authors:  Hui Li; Yanzhen Chen; Xing Tian; Yu Hong; Chengliang Chen; Nawaz Khukhar Sharokh; Jian Jiao
Journal:  Arch Med Sci Atheroscler Dis       Date:  2019-08-06

10.  Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014.

Authors:  Ju Whi Kim; Kyung Jae Lee; Hye Ran Yang; Ju Young Chang; Jin Soo Moon; Young-Ho Khang; Jae Sung Ko
Journal:  BMC Public Health       Date:  2018-05-11       Impact factor: 3.295

View more
  1 in total

1.  Association between serum alanine and aspartate aminotransferase and blood pressure: a cross-sectional study of Chinese freshmen.

Authors:  Lijun Zhu; Zhengmei Fang; Yuelong Jin; Weiwei Chang; Mengyun Huang; Lianping He; Yan Chen; Yingshui Yao
Journal:  BMC Cardiovasc Disord       Date:  2021-10-01       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.